Diagnosis and Treatment of Acute Humoral Kidney Allograft Rejection

Transplantation Proceedings

Volumn 41, Issue 3, 2009, Pages 855-858

  Gomes, A M ^a   Pedroso, S ^b   Martins, L S ^b   Malheiro, J ^b   Viscayno, J R ^b   Santos, J ^b   Dias, L ^b   Henriques, A C ^b   Sarmento, A M ^b   Cabrita, A ^b  

^a Centro Hospitalar Vila Nova Gaia/Espinho   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DACLIZUMAB; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY ALLOGRAFT REJECTION; MALE; PLASMAPHERESIS; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIBODY FORMATION; BIOPSY; CREATININE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMAPHERESIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 64649085709     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.062     Document Type: Article

References (16)

1. Colvin R. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 18 (2007) 1046
2. Terasaki P., and Mizutani K. Antibody mediated rejection: update 2006. Clin J Am Soc Nephrol 1 (2006) 400
3. Terasaki P. Humoral theory of transplantation. Am J Transplant 3 (2003) 665
4. Böhming G., and Regele H. Diagnosis and treatment of antibody-mediated kidney allograft rejection. Transpl Int 16 (2003) 773
5. Akalin E., and Pascual M. Sensitization after kidney transplantation. Clin J Am Soc Nephrol 1 (2006) 433
6. Tinckam K., and Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol 1 (2006) 404
7. Ibernón M., Gil-Vernet S., Carrera M., et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 37 (2005) 3743
8. Shuming M., Zheng T., Daxi J., et al. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection. Clin Transplant 19 (2005) 51
9. Faguer S., Kamar N., Guilbeaud-Frugier C., et al. Rituximab therapy for acute humoral rejection after kidney transplantation. Transplantation 83 (2007) 1277
10. White N., Greenstein S., Cantafio A., et al. Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 78 (2004) 772
11. Shah A., Nadasdy T., Arend L., et al. Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin. Transplantation 77 (2004) 1399
12. Rocha P., Butterly D., Greenberg A., et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 75 (2003) 1490
13. Montgomery R., Zachary A., Racusen L., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70 (2000) 887
14. Becker Y. Rituximab as treatment for refractory kidney transplant rejection. Am J Transpl 4 (2004) 996
15. Crespo M., Oppenheimer F., Venetz J.P., et al. Treatment of humoral rejection in kidney transplantation. Transplant Rev 20 (2006) 95
16. Solez K., Colvin B., Racusen L., et al. Banff 2007 Classification of Renal Allograft Pathology Updates and Future Directions. Am J Transpl 8 (2008) 753